Menu Search
Equities

Guardian Pharmacy Services, Inc.

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GRDN:NYQ

Guardian Pharmacy Services, Inc.

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (USD)39.47
  • Today's Change-0.21 / -0.53%
  • Shares traded426.03k
  • 1 Year change+61.96%
  • Beta--
Data delayed at least 15 minutes, as of Oct 16 2026 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations.

  • Revenue in USD (TTM)1.46bn
  • Net income in USD65.91m
  • Incorporated2021
  • Employees3.60k
  • Location
    Guardian Pharmacy Services, Inc.Suite 800300 Galleria Parkway SEATLANTA 30339United StatesUSA
  • Phone+1 (404) 810-0089
  • Fax+1 (888) 717-7274
  • Websitehttps://guardianpharmacy.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		GRDN:NYQ since
announced		Transaction
value
North Ridge Pharmacy IncDeal completed21 Jan 202621 Jan 2026Deal completed39.37%--
Data delayed at least 15 minutes, as of Oct 16 2026 21:00 BST.

Institutional shareholders

26.54%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 30 Jun 20262.41m4.85%
Wellington Management Co. LLPas of 30 Jun 20261.60m3.22%
BlackRock Fund Advisorsas of 30 Jun 20261.40m2.81%
Vanguard Capital Management LLCas of 30 Jun 20261.38m2.77%
Woodline Partners LPas of 30 Jun 20261.31m2.62%
Valiant Capital Management LPas of 30 Jun 20261.19m2.38%
T. Rowe Price Investment Management, Inc.as of 30 Jun 20261.12m2.24%
Boston Partners Global Investors, Inc.as of 30 Jun 2026983.87k1.98%
TimesSquare Capital Management LLCas of 30 Jun 2026951.64k1.91%
Loomis, Sayles & Co. LPas of 30 Jun 2026869.84k1.75%
More ▼
Data from 30 Jun 2026 - 30 Jun 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.